Life Sciences 2027
November 8–9, 2027 | IPWatchdog Studios | Ashburn, Virginia
Join us November 8–9, 2027, for Life Sciences Masters™ 2027, the sixth annual IPWatchdog conference examining the intellectual property, regulatory, legal, and commercial issues that influence biopharmaceutical innovation.
Bringing together experienced patent attorneys, in-house counsel, industry executives, and other professionals, this high-level, interactive, limited-enrollment program will examine the challenges and strategic decisions that arise throughout the biopharmaceutical lifecycle. Discussions will span the scientific and clinical complexities of developing new medicines, the protection and commercialization of intellectual property, and the economic, competitive, and regulatory conditions that influence whether promising treatments ultimately reach patients.
Innovation does not end with the discovery of a promising molecule. Protecting and bringing new therapies to market requires navigating an interconnected series of scientific, legal, financial, and business decisions. Life Sciences Masters™ 2027 will consider how intellectual property rights and regulatory exclusivities shape investment and competition, how government policy continues to affect the industry, and how emerging technologies are transforming research, development, and commercial strategy.
The program will explore six important areas affecting the life sciences industry:
- Patent Prosecution and Portfolio Strategy: Strategies for securing and maintaining meaningful patent protection throughout drug discovery and development, addressing pre-filing challenges, navigating prosecution, and optimizing patent term and exclusivity.
- Patent Litigation and Enforcement: The legal and practical considerations involved in asserting and defending patent rights, including litigation exposure, PTAB proceedings, changing judicial doctrines, and enforcement strategy.
- Regulatory and Government Policy: The impact of congressional activity, USPTO and FDA developments, and other government initiatives on intellectual property rights, drug pricing, market competition, and incentives to invest in innovation.
- Licensing, Financing, and Commercialization: The role of intellectual property in attracting investment, establishing licensing relationships, pursuing strategic business opportunities, and successfully commercializing innovative therapies.
- Artificial Intelligence and Emerging Technologies: The opportunities and risks created by artificial intelligence as it changes drug discovery, R&D practices, patent strategy, and the competitive landscape.
- In-House IP Leadership: The challenges of overseeing intellectual property strategy within life sciences companies, reconciling legal considerations with commercial objectives, and making decisions that advance long-term innovation.
A defining feature of Life Sciences Masters™ is its integrated approach to these issues. Patent law, scientific progress, regulatory policy, and business strategy cannot be considered in isolation. Decisions taken early in the innovation process can have significant consequences for development, investment, competitive positioning, and enforcement years later.
Through candid exchanges and substantive discussions, experienced practitioners and in-house industry leaders will examine these connections, offering practical insight into managing uncertainty, assessing legal and commercial exposure, safeguarding valuable innovations, and making sound strategic decisions.
The program is designed to go beyond identifying new developments. Its purpose is to help attendees understand their broader implications and acquire the perspective and practical strategies needed to navigate an increasingly complicated and competitive life sciences environment.
Join us for two days of substantive programming, strategic discussions, and valuable networking with leading members of the life sciences and intellectual property communities. Enrollment will be intentionally limited, creating an environment that encourages meaningful interaction, open dialogue, and direct engagement between speakers and attendees.
Register early to reserve your place at Life Sciences Masters™ 2027. Participate in the discussions that will help shape the future of biopharmaceutical innovation, intellectual property protection, and commercialization.

Discounts are available for all full-time in-house/corporate counsel, academic, and government employees. To take advantage of this discount, please complete our discount application form.
Group Discounts are also available to all firms and companies wishing to send multiple people. For more details, click Group Discounts in the menu above.
Sponsorships are also available for this program. If your firm or organization is interested in partnering with us on this program, click Sponsor in the above menu.